{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:15:15Z","timestamp":1788952515034,"version":"build-2803163510"},"reference-count":98,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ncl.2020.08.005","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T18:14:38Z","timestamp":1602180878000},"page":"983-996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Neurotoxicology Syndromes Associated with Drugs of Abuse"],"prefix":"10.1016","volume":"38","author":[{"given":"Rachel A.","family":"Caplan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonah P.","family":"Zuflacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jed A.","family":"Barash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey R.","family":"Fehnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2020.08.005_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2049463712438493","article-title":"Basic opioid pharmacology: an update","volume":"6","author":"Pathan","year":"2012","journal-title":"Br J Pain"},{"key":"10.1016\/j.ncl.2020.08.005_bib3","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0025-6196(11)60749-0","article-title":"A\u00a0comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needs","volume":"84","author":"Argoff","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"15\u201325","key":"10.1016\/j.ncl.2020.08.005_bib4","article-title":"Adverse effects of opioids on the central nervous systems of palliative care patients","volume":"21","author":"Vella-Brincat","year":"2007","journal-title":"J\u00a0Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.ncl.2020.08.005_bib5","first-page":"17","article-title":"Illicit opioid intoxication: diagnosis and treatment","volume":"5","author":"Fareed","year":"2011","journal-title":"Subst Abuse"},{"issue":"76","key":"10.1016\/j.ncl.2020.08.005_bib6","first-page":"79","article-title":"Cluster of an unusual amnestic syndrome - Massachusetts, 2012-2016","volume":"66","author":"Barash","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ncl.2020.08.005_bib7","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMc1716355","article-title":"Acute amnestic syndrome with fentanyl overdose","volume":"378","author":"Barash","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2020.08.005_bib8","series-title":"Neurological aspects of substance abuse","author":"Brust","year":"2004"},{"key":"10.1016\/j.ncl.2020.08.005_bib9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMra1202561","article-title":"Management of opioid analgesic overdose","volume":"367","author":"Boyer","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2020.08.005_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/ajad.12862","article-title":"Effective management of opioid withdrawal symptoms: a gateway to opioid dependence treatment","volume":"28","author":"Kosten","year":"2019","journal-title":"Am J Addict"},{"key":"10.1016\/j.ncl.2020.08.005_bib11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJMra1604339","article-title":"Treatment of opioid-use disorders","volume":"375","author":"Schuckit","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2020.08.005_bib12","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","article-title":"Hospitalizations related to opioid abuse\/dependence and associated serious infections from 2002 to 2012","volume":"35","author":"Ronan","year":"2016","journal-title":"Health Aff (Millwood)"},{"issue":"6","key":"10.1016\/j.ncl.2020.08.005_bib13","article-title":"Memory function in opioid-dependent patients treated with methadone or buprenorphine along with benzodiazepine: longitudinal change in comparison to healthy individuals","volume":"4","author":"Rapeli","year":"2009","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.1016\/j.ncl.2020.08.005_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/B978-0-444-62619-6.00006-9","article-title":"Molecular basis of alcoholism","volume":"125","author":"Most","year":"2014","journal-title":"Handbook Clin Neurol"},{"key":"10.1016\/j.ncl.2020.08.005_bib17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ejim.2007.06.033","article-title":"Acute alcohol intoxication","volume":"19","author":"Vonghia","year":"2008","journal-title":"Eur J Intern Med"},{"issue":"14\u201326","key":"10.1016\/j.ncl.2020.08.005_bib18","article-title":"Acute care for alcohol intoxication: be prepared to consider clinical dilemmas","volume":"112","author":"Yost","year":"2002","journal-title":"Postgrad Med"},{"key":"10.1016\/j.ncl.2020.08.005_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/ane.12671","article-title":"Alcohol withdrawal syndrome: mechanisms, manifestations, and management","volume":"135","author":"Jesse","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ncl.2020.08.005_bib20","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/archinte.164.13.1405","article-title":"Management of alcohol withdrawal delirium. An evidence-based practice guideline","volume":"164","author":"Mayo-Smith","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ncl.2020.08.005_bib21","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","article-title":"Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar)","volume":"84","author":"Sullivan","year":"1989","journal-title":"Br J Addict"},{"key":"10.1016\/j.ncl.2020.08.005_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.35946\/arcr.v38.2.05","article-title":"Alcoholic myopathy: pathophysiologic mechanisms and clinical implications","volume":"38","author":"Simon","year":"2017","journal-title":"Alcohol Res"},{"key":"10.1016\/j.ncl.2020.08.005_bib23","series-title":"Alcoholic neuropathy","author":"Sadowski","year":"2019"},{"key":"10.1016\/j.ncl.2020.08.005_bib24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2125.2011.04111.x","article-title":"Alcoholic neuropathy: possible mechanisms and future treatment possibilities","volume":"73","author":"Chopra","year":"2012","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.ncl.2020.08.005_bib25","article-title":"Alcohol-related dementia: an update of the evidence","volume":"5","author":"Ridley","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.ncl.2020.08.005_bib26","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.2147\/NDT.S130078","article-title":"Korsakoff\u2019s syndrome: a critical review","volume":"13","author":"Arts","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.ncl.2020.08.005_bib27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12916-016-0721-4","article-title":"Differing association of alcohol consumption with different stroke types: a systematic review and meta-analysis","volume":"14","author":"Larsson","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.ncl.2020.08.005_bib28","first-page":"67","article-title":"Marchiafava-Bignami disease: literature review and case report","volume":"13","author":"Kohler","year":"2000","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2020.08.005_bib29","first-page":"75","article-title":"Epidiolex (Cannabidiol) Primer: Frequently Asked Questions for Patients and Caregivers","volume":"25","author":"Abu-Sawwa","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.ncl.2020.08.005_bib30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.biopsych.2016.01.004","article-title":"Changes in Cannabis Potency Over the Last 2 Decades (1995-2014): Analysis of Current Data in the United States","volume":"79","author":"ElSohly","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.ncl.2020.08.005_bib31","unstructured":"Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network, 2010: National Estimates of Drug-Related Emergency Department Visits. HHS Publication No. (SMA) 12-4733, DAWN Series D-38. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2012."},{"issue":"23","key":"10.1016\/j.ncl.2020.08.005_bib32","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMra1402309","article-title":"Adverse health effects of marijuana use","volume":"379","author":"Volkow","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2020.08.005_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.pharmtox.38.1.179","article-title":"Cannabinoid receptors and their endogenous agonists","volume":"38","author":"Felder","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.ncl.2020.08.005_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-198916010-00001","article-title":"Clinical pheramacokinetics of non-opiate abused drugs","volume":"16","author":"Busto","year":"1989","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ncl.2020.08.005_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/02791072.1988.10524379","article-title":"Marijuana metabolism in the context of urine testing for cannabinoid metabolites","volume":"20","author":"Morgan","year":"1988","journal-title":"J\u00a0Psychoactive Drugs"},{"issue":"7","key":"10.1016\/j.ncl.2020.08.005_bib36","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/npp.2012.8","article-title":"Dose-related modulation of event-related potentials to novel and target stimuli by intravenous \u0394\u2079-THC in humans","volume":"37","author":"D'Souza","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ncl.2020.08.005_bib37","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0893-133X(01)00425-0","article-title":"Effects of smoking majirjuana on brain perfusion and cognition","volume":"26","author":"O\u2019leary","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ncl.2020.08.005_bib38","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1212\/01.WNL.0000031422.66442.49","article-title":"Dose-related neurocognitive effects of marijuana use","volume":"59","author":"Bolla","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2020.08.005_bib39","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/bmj.325.7374.1199","article-title":"Self-reprted cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969; historical cohort study","volume":"325","author":"Zammit","year":"2002","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.ncl.2020.08.005_bib40","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/014107689909200803","article-title":"Cocaine: History, Use, Abuse","volume":"92","author":"Karch","year":"1999","journal-title":"J\u00a0R Soc Med"},{"key":"10.1016\/j.ncl.2020.08.005_bib41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fneur.2015.00075","article-title":"Psychostimulants and Movement Disorders","volume":"6","author":"Asser","year":"2015","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2020.08.005_bib42","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/AAP.0b013e31825051f3","article-title":"Carl Koller, Cocaine, and Local Anesthesia","volume":"37","author":"Goerig","year":"2012","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.ncl.2020.08.005_bib43","series-title":"Selected tables of National estimates of drug-related emergency department visits 2011","author":"Center for Behavioral Health Statistics and Quality","year":"2013"},{"issue":"17","key":"10.1016\/j.ncl.2020.08.005_bib44","doi-asserted-by":"crossref","first-page":"388","DOI":"10.15585\/mmwr.mm6817a3","article-title":"Drug Overdose Deaths Involving Cocaine and Psychostimulants with Abuse Potential \u2014 United States, 2003\u20132017","volume":"68","author":"Kariisa","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.ncl.2020.08.005_bib45","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2105\/AJPH.2016.303627","article-title":"Recent Increases in Cocaine-Related Overdose Deaths and the Role of Opioids","volume":"107","author":"Jones","year":"2017","journal-title":"Am J Public Health"},{"issue":"24","key":"10.1016\/j.ncl.2020.08.005_bib46","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1161\/CIRCULATIONAHA.110.940569","article-title":"Cardiovascular effects of cocaine","volume":"122","author":"Schwartz","year":"2010","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ncl.2020.08.005_bib47","first-page":"301","article-title":"Delusions and hallucinations of cocaine abusers and paranoid schizophrenics: a comparative study","volume":"125","author":"Mitchell","year":"1991","journal-title":"J\u00a0Psychol"},{"issue":"9","key":"10.1016\/j.ncl.2020.08.005_bib48","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.amjmed.2012.02.019","article-title":"Psychoactive \"bath salts\" intoxication with methylenedioxypyrovalerone","volume":"125","author":"Ross","year":"2012","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.ncl.2020.08.005_bib49","first-page":"368","article-title":"Cocaine and cognition: a systematic quantitative review","volume":"8","author":"Potvin","year":"2014","journal-title":"J\u00a0Addict Med"},{"issue":"4","key":"10.1016\/j.ncl.2020.08.005_bib50","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/STROKEAHA.115.011417","article-title":"Cocaine Use and Risk of Ischemic Stroke in Young Adults","volume":"47","author":"Cheng","year":"2016","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.ncl.2020.08.005_bib51","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1161\/STROKEAHA.111.000749","article-title":"Impact of acute cocaine use on aneurysmal subarachnoid hemorrhage","volume":"44","author":"Chang","year":"2013","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.ncl.2020.08.005_bib52","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1212\/WNL.0000000000007666","article-title":"Clinical characteristics and outcomes of methamphetamine-associated intracerebral hemorrhage","volume":"93","author":"Swor","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2020.08.005_bib53","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.atherosclerosis.2017.03.019","article-title":"Vascular disease in cocaine addiction","volume":"262","author":"Bachi","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ncl.2020.08.005_bib54","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12883-015-0467-1","article-title":"Multifocal leukoencephalopathy in cocaine users: a report of two cases and review of the literature","volume":"15","author":"Vosoughi","year":"2015","journal-title":"BMC Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2020.08.005_bib55","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1212\/WNL.39.8.1037","article-title":"Seizures associated with recreational drug abuse","volume":"39","author":"Alldredge","year":"1989","journal-title":"Neurology"},{"issue":"3 Pt 1","key":"10.1016\/j.ncl.2020.08.005_bib56","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1212\/WNL.40.3_Part_1.404","article-title":"Cocaine-induced seizures","volume":"40","author":"Pascual-Leone","year":"1990","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ncl.2020.08.005_bib57","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJM198903093201011","article-title":"Acute rhabdomyolysis associated with cocaine intoxication","volume":"320","author":"Roth","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2020.08.005_bib58","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fneur.2015.00075","article-title":"Psychostimulants and movement disorders","volume":"6","author":"Asser","year":"2015","journal-title":"Front Neurol"},{"issue":"1\u20132","key":"10.1016\/j.ncl.2020.08.005_bib59","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.drugalcdep.2008.02.005","article-title":"Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding","volume":"96","author":"Fasano","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1016\/j.ncl.2020.08.005_bib60","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/15563650.2016.1142090","article-title":"Treatment of cocaine cardiovascular toxicity: a systematic review","volume":"54","author":"Richards","year":"2016","journal-title":"Clin Toxicol (Phila)"},{"issue":"2","key":"10.1016\/j.ncl.2020.08.005_bib61","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.annemergmed.2007.08.011","article-title":"Cocaine and beta-blockers: should the controversy continue?","volume":"51","author":"Hoffman","year":"2008","journal-title":"Ann Emerg Med"},{"issue":"12","key":"10.1016\/j.ncl.2020.08.005_bib62","first-page":"44","article-title":"New Medications for the Treatment of Cocaine Dependence","volume":"2","author":"Kampman","year":"2005","journal-title":"Psychiatry"},{"issue":"9320","key":"10.1016\/j.ncl.2020.08.005_bib63","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0140-6736(02)08701-9","article-title":"Mescaline use for 5700 years","volume":"359","author":"Bruhn","year":"2002","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.ncl.2020.08.005_bib64","doi-asserted-by":"crossref","first-page":"11207","DOI":"10.1073\/pnas.1902174116","article-title":"Chemical evidence for the use of multiple psychotropic plants in a 1,000-year-old ritual bundle from South America","volume":"116","author":"Miller","year":"2019","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ncl.2020.08.005_bib65","first-page":"106300","article-title":"Ayahuasca, an ancient substance with traditional and contemporary use in neuropsychiatry and neuroscience","author":"Dos Santos","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.ncl.2020.08.005_bib66","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/02791072.1988.10472512","article-title":"Some Little-Known Hallucinogenic Plants of the Aztecs","volume":"20","author":"Elferink","year":"1988","journal-title":"J\u00a0Psychoactive Drugs"},{"key":"10.1016\/j.ncl.2020.08.005_bib67","series-title":"Teonanacatl: sacred mushroom of visions","author":"Metzner","year":"2004"},{"key":"10.1016\/j.ncl.2020.08.005_bib68","series-title":"Ethnopharmacology","first-page":"128","article-title":"Psychoactive botanicals in ritual, religion and shamanism","author":"Shepard","year":"2005"},{"key":"10.1016\/j.ncl.2020.08.005_bib69","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/02791072.1979.10472092","article-title":"How LSD originated","volume":"11","author":"Hoffman","year":"1979","journal-title":"J\u00a0Psychedelic Drugs"},{"issue":"2","key":"10.1016\/j.ncl.2020.08.005_bib70","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ncl.2020.08.005_bib71","doi-asserted-by":"crossref","first-page":"98","DOI":"10.12688\/f1000research.2-98.v1","article-title":"Over 30 million psychedelic users in the United States","volume":"2","author":"Krebs","year":"2013","journal-title":"F1000Res"},{"key":"10.1016\/j.ncl.2020.08.005_bib72","series-title":"World drug report","year":"2017"},{"issue":"3","key":"10.1016\/j.ncl.2020.08.005_bib73","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/03602532.2019.1638931","article-title":"Metabolism of lysergic acid diethylamide (LSD): an update","volume":"51","author":"Libanio Osorio Marta","year":"2019","journal-title":"Drug Metab Rev"},{"issue":"2","key":"10.1016\/j.ncl.2020.08.005_bib75","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0091-3057(99)00045-3","article-title":"Arylalkylamine drugs of abuse: an overview of drug discrimination studies","volume":"64","author":"Glennon","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.ncl.2020.08.005_bib76","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cub.2016.12.030","article-title":"The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation","volume":"27","author":"Preller","year":"2017","journal-title":"Curr Biol"},{"issue":"8","key":"10.1016\/j.ncl.2020.08.005_bib77","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.euroneuro.2016.05.001","article-title":"Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens","volume":"26","author":"Rickli","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"issue":"10","key":"10.1016\/j.ncl.2020.08.005_bib78","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s40262-017-0513-9","article-title":"Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects","volume":"56","author":"Dolder","year":"2017","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.ncl.2020.08.005_bib79","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00213-017-4769-4","article-title":"Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences","volume":"235","author":"Carbonaro","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"issue":"11","key":"10.1016\/j.ncl.2020.08.005_bib80","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/npp.2017.86","article-title":"Modern Clinical Research on LSD","volume":"42","author":"Liechti","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.ncl.2020.08.005_bib81","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/JCP.0b013e31823607f6","article-title":"Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine","volume":"31","author":"Dos Santos","year":"2011","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.ncl.2020.08.005_bib82","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4161\/oxim.2.4.9380","article-title":"Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships","volume":"2","author":"Kovacic","year":"2009","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"10.1016\/j.ncl.2020.08.005_bib83","first-page":"533","article-title":"Serotonin syndrome","volume":"13","author":"Volpi-Abadie","year":"2013","journal-title":"Ochsner J"},{"issue":"11","key":"10.1016\/j.ncl.2020.08.005_bib84","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1038\/npp.2016.82","article-title":"LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality","volume":"41","author":"Dolder","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.ncl.2020.08.005_bib85","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00213-011-2358-5","article-title":"Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects","volume":"218","author":"Griffiths","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"issue":"17","key":"10.1016\/j.ncl.2020.08.005_bib86","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1073\/pnas.1518377113","article-title":"Neural correlates of the LSD experience revealed by multimodal neuroimaging","volume":"113","author":"Carhart-Harris","year":"2016","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"1","key":"10.1016\/j.ncl.2020.08.005_bib87","doi-asserted-by":"crossref","first-page":"nix016","DOI":"10.1093\/nc\/nix016","article-title":"Self unbound: ego dissolution in psychedelic experience","volume":"2017","author":"Letheby","year":"2017","journal-title":"Neurosci Conscious"},{"issue":"4","key":"10.1016\/j.ncl.2020.08.005_bib88","doi-asserted-by":"crossref","first-page":"e0214377","DOI":"10.1371\/journal.pone.0214377","article-title":"Survey of subjective \"God encounter experiences\": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT","volume":"14","author":"Griffiths","year":"2019","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ncl.2020.08.005_bib89","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tips.2008.06.006","article-title":"Serotonin research: contributions to understanding psychoses","volume":"29","author":"Geyer","year":"2008","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"10.1016\/j.ncl.2020.08.005_bib90","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1073\/pnas.1815129116","article-title":"Effective connectivity changes in LSD-induced altered states of consciousness in humans","volume":"116","author":"Preller","year":"2019","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"3","key":"10.1016\/j.ncl.2020.08.005_bib91","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/jama.1970.03170290018003","article-title":"Management of \"Bad Trips\" in an Evolving Drug Scene","volume":"213","author":"Taylor","year":"1970","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ncl.2020.08.005_bib92","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jama.1968.03140350054015","article-title":"Use of Diazepam in Hallucinogenic Drug Crises","volume":"205","author":"Solursh","year":"1968","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ncl.2020.08.005_bib93","first-page":"295","article-title":"25C-NBOMe Ingestion","volume":"1","author":"Zygowiec","year":"2017","journal-title":"Clin Pract Cases Emerg Med"},{"key":"10.1016\/j.ncl.2020.08.005_bib94","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3389\/fpsyt.2017.00240","article-title":"The \"Endless Trip\" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review","volume":"8","author":"Orsolini","year":"2017","journal-title":"Front Psychiatry"},{"issue":"3","key":"10.1016\/j.ncl.2020.08.005_bib95","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0376-8716(98)00129-X","article-title":"Do hallucinogens cause residual neuropsychological toxicity?","volume":"53","author":"Halpern","year":"1999","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.ncl.2020.08.005_bib96","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/0269881114568039","article-title":"Psychedelics not linked to mental health problems or suicidal behavior: a population study","volume":"29","author":"Johansen","year":"2015","journal-title":"J\u00a0Psychopharmacol"},{"issue":"7\u20138","key":"10.1016\/j.ncl.2020.08.005_bib97","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/dta.1383","article-title":"Health status of ayahuasca users","volume":"4","author":"Barbosa","year":"2012","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.ncl.2020.08.005_bib98","author":"Abuse NIoD"},{"issue":"1","key":"10.1016\/j.ncl.2020.08.005_bib99","first-page":"9","article-title":"Phencyclidine Intoxication and Adverse Effects: A Clinical and Pharmacological Review of an Illicit Drug","volume":"8","author":"Bey","year":"2007","journal-title":"Cal J Emerg Med"},{"key":"10.1016\/j.ncl.2020.08.005_bib100","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.3402\/ehtj.v4i0.7107","article-title":"The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use","volume":"4","author":"Kalsi","year":"2011","journal-title":"Emerg Health Threats J"},{"issue":"3","key":"10.1016\/j.ncl.2020.08.005_bib101","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/practneurol-2014-001071","article-title":"Whippits, nitrous oxide and the dangers of legal highs","volume":"15","author":"Thompson","year":"2015","journal-title":"Pract Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2020.08.005_bib102","first-page":"18","article-title":"Inhalant Use and Inhalant Use Disorders in the United States","volume":"6","author":"Howard","year":"2011","journal-title":"Addict Sci Clin Pract"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861920300669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861920300669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:18:27Z","timestamp":1760005107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861920300669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0733861920300669"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2020.08.005","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurotoxicology Syndromes Associated with Drugs of Abuse","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2020.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}